Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment.
about
Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant ApproachesDepression and the Link with Cardiovascular DiseaseHeart rate characteristics: physiomarkers for detection of late-onset neonatal sepsis.Vagus Nerve Stimulation.Depressive behavior and vascular dysfunction: a link between clinical depression and vascular disease?Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporter.Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients.A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables.Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Effect and mechanism of fluoxetine on electrophysiology in vivo in a rat model of postmyocardial infarction depression.Efficacy of lifestyle interventions in physical health management of patients with severe mental illness.Traumatic stress and cardiopulmonary disease burden among low-income, urban heart failure patients.Respiratory sinus arrhythmia is reduced in adolescent major depressive disorder.Comorbidity profile and healthcare utilization in elderly patients with serious mental illnessesAbnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depressionDepression or anxiety and all-cause mortality in adults with atrial fibrillation--A cohort study in Swedish primary care.Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction.Describing the population health burden of depression: health-adjusted life expectancy by depression status in Canada.Effect of depression and sertraline treatment on cardiac function in female nonhuman primatesA systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality.Therapeutic interventions for vascular depression: a systematic review.Mind and heart: heart rate variability in major depressive disorder and coronary heart disease - a review and recommendations.The interface of physical and mental health.An exploratory investigation of sexual health screening in the first 12 weeks of case management in populations with severe mental illness.Sexual victimization history, depression, and task physiology as predictors of sexual revictimization: results from a 6-month prospective pilot study.A closer look at the relationship between the default network, mind wandering, negative mood, and depression.A polymorphism in the norepinephrine transporter gene is associated with affective and cardiovascular disease through a microRNA mechanism.RISK OF NEW ONSET TYPE II DM IN MDD PATIENTS RECEIVING SECOND-GENERATION ANTIPSYCHOTICS TREATMENT: A NATIONWIDE COHORT STUDY.Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: a cross-sectional study.Dietary fats in relation to depressive symptoms by cardiovascular disease risk factors status of elderly people living in Mediterranean islands.Changes in metabolic parameters in patients with severe mental illness over a 10-year period: A retrospective cohort study.Hypothalamo-pituitary adrenal axis and sympatho-adrenal medullary system responses to psychological stress were not attenuated in women with elevated physical fitness levels.Anxiety disorders are associated with increased plasma adrenomedullin level and left ventricular hypertrophy in patients with hypertension.Depression, antidepressant treatment and the cardiovascular system.Liraglutide Activates mTORC1 Signaling and AMPA Receptors in Rat Hippocampal Neurons Under Toxic Conditions
P2860
Q26738789-DB680616-E420-4323-9BB4-F644A05B6287Q26752379-542DBD90-B4BE-4968-B6E2-4691CB485532Q30430820-15286C17-99AD-4DD7-A828-24DAD948F3E2Q33595296-F21827BC-625D-45D7-BCDB-F09C10EAFA30Q33841229-83E662A0-7A63-4E4A-A4FC-7C37682DB361Q34150552-331DDF74-A694-4F91-A6C5-41AACB986AC6Q34182611-68CF191D-065F-477B-AE09-DF23888EC604Q34183522-8940A328-ACFF-43A6-9433-4754AB7C4C1CQ34386877-812F1115-865E-4D17-9952-C9CB1B212B34Q34623350-878C6A66-0A2C-46D0-A540-1008AF64B8A1Q35088018-AD90144C-26A3-42C4-8451-68AB3AA0FBA1Q35290463-67DB505D-F5A4-45D5-95B9-1CF805852A92Q36387272-9304A436-0657-4462-A782-6D3DCF354EACQ36464192-AA90CE5A-F89A-4A40-B4CE-02F17A6B584AQ36609245-2B1A6300-F44D-4A2E-A636-7BBD62A81DF7Q36653387-763C3E6F-DCD1-4078-9639-0FE8C09ECE61Q36682800-B63C9A5F-8898-401F-A86F-227F9DFCE928Q37265891-8D66CAC9-6C01-4B67-9CAD-53C6670642D4Q37506217-47A58C3E-88A0-4400-AFD5-CE45D732715AQ37677026-120175FE-BF79-4C5E-8E88-7413DF5381DFQ37798087-F33A63D3-94BD-45AF-A4B7-98F011225F11Q37970618-29DE8CBD-B7C1-4C19-B3BF-5656FAF0069CQ38005086-FCCE2010-CA3D-4E0B-952F-1D016EDF8D09Q38190416-D12A78FD-38C2-4BAD-9311-BFD0E89385CBQ40544097-DEC3F9A1-9871-478E-A517-F59E26FF93B9Q44999274-5FE78AF2-E83A-4DFB-B9B4-553F8300124AQ47921801-A463F4A6-75D1-40DE-97B7-0CBF7BF4CB9AQ48059089-63161551-C4FE-49F1-A16D-9F740C4BFB1DQ48060784-1C31B5E4-E02E-41A6-A1B7-18FB7AB56C80Q48684809-961DA6B0-2591-4DCE-857E-2A90AEF5F35CQ48970780-9C2D33E8-DFFA-4703-AC5D-66EC56697EA3Q50546113-33450398-C47D-480B-A980-20F2F1871531Q50885310-05479CDA-385F-400E-8268-CC3692F3AB22Q51024147-F007E771-12EF-4B87-862E-F2889DF9EE4DQ57253298-A0694017-87CF-432D-ABCA-2BBA7F0BDE63Q58573252-733C44D1-C672-4071-B9A7-7F9F3F6391F4
P2860
Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiovascular abnormalities i ...... nd implications for treatment.
@en
Cardiovascular abnormalities i ...... nd implications for treatment.
@nl
type
label
Cardiovascular abnormalities i ...... nd implications for treatment.
@en
Cardiovascular abnormalities i ...... nd implications for treatment.
@nl
prefLabel
Cardiovascular abnormalities i ...... nd implications for treatment.
@en
Cardiovascular abnormalities i ...... nd implications for treatment.
@nl
P2860
P1433
P1476
Cardiovascular abnormalities i ...... and implications for treatment
@en
P2093
David A Barton
Gavin W Lambert
P2860
P304
P356
10.2165/00023210-200923070-00004
P50
P577
2009-01-01T00:00:00Z
P5875
P6179
1009755588